Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	In this study we describe a new expression and purification protocol for recombinant M. tuberculosis topoisomerase I capable of producing milligrams of pure protein.	5
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	We overcame these difficulties by expressing MtTOP from a recombinant plasmid pLIC-MTOP in an E. coli Arctic express (DE3)RP strain (Stratgene) at low temperatures (12 C).	4
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Induction of T7 RNA polymerase protein synthesis with IPTG resulted in the expression of the T7 promoter-driven recombinant protein.	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	In addition the Arctic express (DE3)RP strain expressed cold chaperonin proteins (Cpn10 and CPn60) and extra copies of tRNAs (recognizing arginine and proline codons) that facilitated the expression of recombinant proteins by overcoming issues of protein solubility and codon bias respectively.	1
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Recombinant MtTOP was soluble and initially expressed as a hexa-histidine fusion protein only in the presence of IPTG (Figure 1).	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Purification of the fusion protein was achieved using nickel affinity chromatography.	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The hexa-histidine fusion tag was cleaved off by TEV protease treatment and MtTOP of high purity was eluted by increasing the potassium chloride gradient from a single-stranded DNA cellulose column (Figure 2B) .	2
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The eluted fractions were pooled and dialyzed into storage buffer.	1
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Approximately 12 milligrams of purified protein was obtained from 7 L of bacterial culture in LB medium.	4
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Results indicated that 100 ng of EcTOP and 500 ng of MtTOP (Figure 3A) constitute one unit of enzyme activity.	1
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Here we report that by utilizing the E. coli Arctic express RP(DE3) strain we took advantage of the higher GC rich codon usage efficiency and low temperature chaperone in this strain to obtain soluble MtTOP in high yield (12 mg from 7 L of bacterial culture).	4
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	A new procedure for expression and purification of recombinant MtTOP protein in high yield has been described.	5
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	MtTOP was expressed from a recombinant plasmid pLIC-MTOP in E.coli Arctic express (DE3)RP strain (Stratagene).	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	MtTOP coding sequence was amplified from the genomic DNA of M. tuberculosis H37RV strain with suitable primers (LIC-Mtop5'-TACTTCCAATCCAATGCAGCTGACCCGAAAACG and LIC-Mtop3'-TTATCCACTTCCAATGTTATTAGTCGCGCTTGGCTGC) using PfuUltra II Fusion HS DNA polymerase (Stratagene) and cloned into a vector pLIC-HK through a ligation independent cloning procedure .	1
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The resulting pLIC-MTOP plasmid capable of expressing recombinant MtTOP was first isolated in E. coli NEB Turbo competent cells (New England Biolabs) and then transformed into Arctic express (DE3)RP cells after sequence confirmation.	2
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Expression of MtTOP in transformed Arctic express (DE3)RP cells was induced by 1 mM IPTG at 12 C according to the manufacturer's (Stratagene) protocol.	4
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The recombinant protein in the soluble lysate was allowed to bind to Ni-NTA agarose (Qiagen) and packed into a column.	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	After washing the column overnight with wash buffer (50 mM NaH2PO4 300 mM NaCl 20 mM imidazole pH 8.0) the topoisomerase protein was eluted with an elution buffer (50 mM NaH2PO4 300 mM NaCl 250 mM Imidazole pH 8.0) containing higher concentrations of imidazole.	3
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Eluted MtTOP was cleaved with TEV protease to remove the N-terminal hexa-histidine tag and purified by passing through a single-stranded DNA cellulose column as described .	2
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Background	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	DNA topoisomerases are ubiquitous enzymes involved in the regulation of DNA supercoiling and overcoming topological barriers during replication transcription recombination and repair.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	In bacteria the major classes of topoisomerases type IA and type IIA modify DNA topology by transiently cleaving and rejoining one or two strands of DNA respectively .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Both of these classes form a 5'-phosphotyrosyl enzyme-DNA linkage during the catalytic cycle of DNA cleavage and religation .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Topoisomerases are attractive targets for development of new anti-infectives .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Bacterial DNA gyrase and topoisomerase IV from the type IIA class are targets of antibiotics such as quinolones and fluoroquinolones.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	These antibiotics exhibit their bactericidal properties by trapping the covalent protein-DNA complexes formed by DNA gyrase or topoisomerase IV .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Although fluoroquinolones are effective against a broad spectrum of bacteria alarming increase in fluoroquinolone-resistant pathogens warrants the need to develop novel drugs against new cellular targets.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Bacterial topoisomerase I responsible for relaxing negatively supercoiled DNA is the most common type IA topoisomerase present in almost all bacteria .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Escherichia coli topoisomerase I (EcTOP) is the well studied prototype for type IA topoisomerase .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	EcTOP relaxes negatively supercoiled DNA through a magnesium-dependent ATP-independent catalytic mechanism.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	No specific inhibitor for bacterial topoisomerase I effective at a relevant clinical and physiological concentration has been identified.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Bacterial topoisomerase I by virtue of its presence in nearly all bacterial genomes and in view of its association with DNA during the vulnerable stage of cleavage-religation could be utilized as a target for novel antimicrobials .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	This strategy could be useful in developing drugs to treat highly fatal bacterial diseases like tuberculosis .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The fact that approximately one-third of the world's population is affected by tuberculosis indicates the need to develop effective drugs against this disease .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Also since multiple drug resistance is common in Mycobacterium tuberculosis it would be significant if a novel antibiotic targeting M. tuberculosis DNA topoisomerase I can be developed .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	A logical first step towards finding inhibitors selective to M. tuberculosis topoisomerase I is to characterize the DNA modification ability of this enzyme.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	We also report the first detailed characterization of this enzyme with respect to its DNA cleavage sites and relaxation activity under different assay conditions.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Results	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Expression and purification of M. tuberculosis topoisomerase I	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Genome sequencing of M. tuberculosis H37Rv strain has revealed the presence of topA gene Rv3646c which encodes a DNA topoisomerase I (MtTOP) comprising of 934 amino acids with an estimated molecular weight of 102.3 kDa .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Previously Yang et al  have cloned and purified DNA topoisomerase I from M. tuberculosis Erdman strain in E. coli BL21 (DE3).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Our efforts to express and purify recombinant MtTOP in E. coli BL21 (DE3) similarly by induction of the T7 promoter were frustrated by the insolubility of the expressed protein.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Difficulties have also been encountered by other researchers  while trying to use recombinant DNA topoisomerase I gene present in genomic libraries of M. tuberculosis and Mycobacterium smegmatis to complement the temperature dependent deficiency of topoisomerase I (topA) function in E. coli strain AS17 .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Difference in codon usage was surmised to be one of the possible reasons behind this result .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The Arctic express (DE3)RP strain contained a chromosomally integrated T7 RNA polymerase which was expressed from the lacUV5 promoter.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Subsequent SDS-PAGE analysis (Figure 2A) showed the predominant presence of only the fusion protein with the expected molecular weight.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Characterization of DNA relaxation activity of M. tuberculosis topoisomerase I	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	DNA relaxation assay was used to characterize the purified MtTOP.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	We compared the ability of MtTOP with that of similarly purified E.coli topoisomerase I (EcTOP)  in relaxing negatively supercoiled DNA by agarose gel electrophoresis.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Initial assays evaluated the minimum amount of enzyme (MtTOP or EcTOP) required to bring about complete relaxation of negatively supercoiled DNA under standard conditions (Figure 3).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	One unit of enzyme was defined as the amount of enzyme required to relax 0.5 ?g of negatively supercoiled plasmid DNA in 30 min at 37Â°C.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	However at lower concentrations of enzyme = 12.5 ng there is no difference between the ability of MtTOP and EcTOP in removing the negative supercoils from the plasmid DNA substrate (Figure 3).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The percent relaxation values reported are averages of at least three independent experiments.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Error bars denote the standard error of mean.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	For a more detailed analysis of the relaxation activity of the purified enzymes a time course assay with 50 ng each of MtTOP and EcTOP was performed (Figure 4).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	At the early time points the rate of removal of the negative supercoils by the two enzymes was similar.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	However as the plasmid DNA substrate became partially relaxed the relaxation activity of MtTOP was less efficient than EcTOP in removing the residual negative supercoils.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	It has been a well known fact that Mg2+ ions are required for the relaxation activity of bacterial type IA topoisomerases including E. coli topoisomerase I .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	We compared the Mg2+dependence of the relaxation activity of EcTOP and MtTOP using two different enzyme concentrations (50 ng or 1 unit in a 20-?l assay) and a range of Mg2+ levels (Figure 5).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	At a lower enzyme concentration (50 ng) relaxation by EcTOP had a optimal range of Mg2+ concentrations between 2.5 to 7.5 mM while the optimal range of Mg2+ concentrations for MtTOP was slightly higher (5?12.5 mM) (Figure 5B).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Similar optimal levels of Mg2+ were found for the relaxation activities of both the EcTOP and MtTOP at higher enzyme concentrations equivalent to one unit of enzyme activity with no relaxation observed in the absence of Mg2+ (Figure 5A).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The optimal Mg2+ concentrations found here for MtTOP are higher than the 1 mM concentration determined in previous work .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	In other studies involving the characterization of the topoisomerase I from M. smegmatis the optimal Mg2+ concentration for relaxation activity was found to be about 5 mM .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Mapping of DNA cleavage sites using single-stranded DNA substrates	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Although the majority of topoisomerases do not have specific sequence requirements for cleavage sites many of them show at least a certain degree of non -randomness in cleavage site recognition .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	For example EcTOP and Micrococcal luteus topoisomerase I cleave the sequence CXXX? (? represents the cleavage site) more preferentially than others .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Archeal and bacterial reverse gyrases which are type IA topoisomerases also have limited sequence requirements with only the preference of a cytosine or requirement of at least a pyrimidine at the -4 position of the cleavage site .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Previous studies elucidating the sequence specificity of topoisomerase I from M. smegmatis reported a strong topoisomerase I site (STS) wherein the enzyme recognizes and cleaves the sequence CG/TCT?T .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	We utilized different single-stranded 5'-32P labeled DNA substrates ranging from ~200?550 bases in length generated from either an E. coli plasmid or M. tuberculosis genomic DNA to characterize the MtTOP preferred cleavage sites.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Results indicate that the DNA cleavage selectivity of MtTOP is very similar to that of EcTOP (Figure 6A Table 1).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The two enzymes share many cleavage sites on DNA derived either from E. coli or M. tuberculosis but some cleavage sites were preferred by only one of these two enzymes (Figure 6B Table 1).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	All of the cleavage sites for both enzymes were found to have a cytosine at the -4 position (CXXX?) as previously shown for many bacterial topoisomerase I enzymes .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	There was no specific cleavage sequence recognition for MtTOP as reported for M. smegmatis topoisomerase I.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Discussion	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Tuberculosis (TB) is the second leading cause of adult deaths due to infectious diseases world-wide second only to HIV.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The surge in multi-drug resistant M. tuberculosis makes it crucial to identify novel targets for development of new TB treatment.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	M. tuberculosis topoisomerase I could be one such novel target since there is only one type IA topoisomerase found in M. tuberculosis.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	A recent genome wide transposon mutagenesis experiment has postulated and categorised M. tuberculosis topA gene as essential .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	It is also likely to be essential because every bacterium has at least one type IA topoisomerase activity.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	MtTOP is therefore an attractive target for drugs which would interfere with its relaxation activity (catalytic inhibitors).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Moreover besides inhibiting the overall relaxation activity of MtTOP a more potent bactericidal effect could be achieved by drugs (catalytic poisons) that enhance the accumulation of covalent complexes on DNA similar to the bactericidal mechanism of fluoroquinolones on type IIA bacterial topoisomerases.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	To aide such drug development efforts it is important to have MtTOP protein in high purity and quantity.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	This enables future development of high through-put assays for inhibitors targeting MtTOP.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The DNA cleavage activity of MtTOP has not been characterized previously and there is a also a need for more detailed analysis of its DNA relaxation activity than in the early study of the enzyme .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Careful comparison with E. coli topoisomerase I (EcTOP) showed that the two enzymes had similar efficiency initially in relaxing the negatively supercoiled plasmid DNA isolated from E. coli.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	However as the substrate plasmid DNA became partially relaxed MtTOP was slower than EcTOP in removing the residual negative supercoils.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	This could be due to the different C-terminal domain found in the enzymes.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The C-terminal domain found in EcTOP has been proposed to be important for substrate binding and coordination of strand passage during the relaxation cycle .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The C-terminal domain of MtTOP has no homology to the C-terminal domain in EcTOP so it may function differently during the catalytic cycle.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The N-terminal two-thirds the transesterification domains of EcTOP and MtTOP have high degree of homology (41.9% identical).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Analysis of cleavage sites on both E. coli and M. tuberculosis derived DNA substrate showed that the cleavage site preferences are quite similar with a C in the -4 position as have been observed for several bacterial topoisomerase I as well as archeal and bacterial reverse gyrase enzymes.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	It is somewhat surprising that the cleavage site preference of MtTOP is not the same as that reported for M. smegmatis topoisomerase I (CG/TCT?T).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	It is possible that this is due to the different experimental protocols used in analysis of the cleavage sites .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Besides M. smegmatis topoisomerase I there are other examples of type IA topoisomerases that have cleavage site preferences different from that of EcTOP.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	These include CTT? for E. coli topoisomerase III  CANNN? for human topoisomerase III  ANN? for yeast topoisomerase III .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	It remains unclear which part of the type IA enzyme structure determines the cleavage site selectivity.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The specific sequence information for DNA cleavage by MtTOP should be useful in design of oligonucleotide substrates for DNA cleavage assays.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Conclusion	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The enzyme is as efficient as EcTOP in initial removal of negative supercoils from plasmid DNA but is less efficient than EcTOP in removing the remaining negative supercoils.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The preferred DNA cleavage sites of MtTOP have limited sequence specificity but contain a C nucleotide in the -4 position similar to most bacterial topoisomerase I and archeal reverse gyrase cleavage sites characterized previously.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Methods	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	MtTOP expression and purification	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Cloning of MtTOP coding sequence into this vector containing a T7 promoter allowed T7 RNA polymerase dependent expression of MtTOP along with a tobacco etch virus (TEV) protease-cleavable N-terminal hexahistidine tag .	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	After 24 h of induction the cells were collected and subjected to freeze-thaw lysis  in lysis buffer (50 mM NaH2PO4 300 mM NaCl 10 mM imidazole 1 mg/ml Lysozyme pH 8.0).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	DNA Relaxation Activity assays	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	To assay for one unit of relaxation activity EcTOP  and MtTOP enzymes of the same concentrations were diluted serially ranging from 500?1 ng and assayed for DNA relaxation activity in a standard reaction volume of 20 ?l with 10 mM Tris-HCl (pH 8.0) 50 mM NaCl 0.1 mg/ml gelatin 6 mM MgCl2 and 0.5 ?g of supercoiled pBAD/thio plasmid DNA (purified by CsCl gradient centrifugation).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	After incubation at 37Â°C for 30 min the reactions were stopped by adding 5 ul of 50 mM EDTA 50% glycerol and 0.5%(v/v) bromophenol blue.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The DNA was electrophoresed in a 1.0% (w/v) agarose gel with TAE buffer (40 mM Tris-acetate pH 8.1 2 mM EDTA).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The gel was stained with ethidium bromide and photographed over UV light.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	One unit of enzyme was defined as the least quantity of the enzyme required for complete relaxation of negatively supercoiled DNA under the given reaction conditions.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Mg2+ dependence of EcTOP and MtTOP to relax negatively supercoiled DNA was compared with either 50 ng or one unit of enzyme (100 ng of EcTOP 500 ng of MtTOP) under varying concentrations of MgCl2 ranging from 0?20 mM over a time period of 30 min at 37Â°C with similar reaction conditions as described above.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Also a low concentration (50 ng) of EcTOP and MtTOP under standard conditions (6 mM MgCl2) as described earlier was used to compare the ability of the respective enzymes to relax negatively supercoiled DNA at various time points of 0 10 20 30 45 60 75 90 120 and 180 sec at 37Â°C.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Cleavage of Single-stranded DNA	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	To compare and map the cleavage sites of EcTOP and MtTOP single stranded DNA substrates were generated first by PCR (Table 2) followed by strand denaturation.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Each of these substrates were radio-labeled at the 5' end by having one of the corresponding forward or reverse primers labeled with [?-32P]ATP in the presence of T4 polynucleotide kinase prior to the PCR.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The PCR products were purified using the DNA Clean and Concentrator Kit (Zymos) and eluted in TE buffer (10 mM Tris-HCl pH 8.0 1 mM EDTA).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Prior to the addition of topoisomerase in the cleavage assay the DNA substrate was denatured to single strands by heating at 95Â°C for 5 min and rapidly cooled on ice.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	After incubation with the topoisomerase at 37Â°C for 10 min trapping of the covalent enzyme-DNA complex and cleaved DNA was achieved by the addition of 0.1 M NaOH.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	After neutralization the DNA was electrophoresed in a 6% polyacrylamide sequencing gel followed by autoradiography of the dried gel to visualize the 5'-end-labeled DNA cleavage products.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	DNA sequencing reaction products were generated with the same 5' end labeled primer corresponding to that of the substrate used in the cleavage assay and by following the cycle sequencing procedures according to the manufacturer's instructions (SequiTherm DNA sequencing Kit Epicentre).	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	The sequencing reaction products were electrophoresed next to lanes containing cleavage products to identify the cleavage sites.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	Authors' contributions	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	AA carried out the relaxation and DNA cleavage assays and drafted the manuscript.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	ND and BC developed and carried out the expression and purification protocol.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	YT conceived the study and participated in the design and coordination and helped to draft the manuscript.	0
Expression and purification procedures utilizing plasmid pLIC-MTOP have been developed to produce milligram quantities of soluble and active MtTOP1 protein.	All authors read and approved the final manuscript.	0
